BioArray Solutions LLC
This article was originally published in Start Up
BioArray solutions has developed an optically programmable array technology designed to perform thousands of different quantitative biomolecular assays in concert. It aims to monitor molecular binding events such as those between antigens and antibodies in immunoassays and pairs of DNA in hybridization assays.
You may also be interested in...
Companies in the new generation of screening technologies are stressing content as much as they're stressing speed, and one-stop shopping as much as focused expertise.
As an industry, women's health is in its infancy. It has yet to develop beyond a collection of niche specialties in reproductive medicine and breast cancer.
EPIcyte has licensed patents from the Scripps Research Institute covering new methods of human antibody production in plants that can lower costs up to 100 fold. The company is also developing proprietary products based on its technology, initially, an anti-herpes prophylactic and a contraceptive based on an anti-sperm antibody.